查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1357993

器官移植免疫抑制劑市場：依藥物類別、移植類型、配銷通路和地區分類

Organ Transplant Immunosuppressant Drugs Market, By Drug Class, By Transplant Type, By Distribution Channel, By geography
出版日期: | 出版商: Coherent Market Insights | 英文 176 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2023年，全球器官移植免疫抑制劑市場規模將達51.7億美元，預計在預測期內（2023-2030年）年複合成長率為3.1%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 51.7億美元
實績資料 2018-2021 預測期 2023-2030
預測期年複合成長率 3.10% 2030年市場規模預測 64億美元
2023 年器官移植用免疫抑制劑的全球市場佔有率（按藥物類別分類）
器官移植免疫抑制劑藥物市場-IMG1

現代醫學中最複雜和最困難的領域之一是移植相關的藥物治療。大多數藥物給藥治療移植排斥和相關問題。人體對移植器官的免疫反應表現為移植排斥反應，通常會導致移植失敗，需要立即從接受者身上摘除器官。給藥免疫抑制藥物和確定供體和受體相容性的血清分型都有助於減少移植排斥。由於全球器官移植數量的增加，預計全球器官移植免疫抑制劑市場將大幅成長。免疫抑制劑對於預防移植後的移植物排斥至關重要，該市場是由器官移植（特別是腎臟、肝臟、心臟和肺移植）的增加所推動的。藥物開發的進步，包括標靶治療治療和個體化治療，正在提高藥物療效，同時最大限度地減少副作用。生物相似藥和競爭形勢正在創造競爭優勢，並有可能降低治療成本。此外，遠端醫療和遠端監控技術正在提高患者的依從性。

市場動態

器官移植免疫抑制劑市場受益於慢性病的增加。糖尿病、心臟病和腎臟損傷等慢性疾病導致的器官衰竭往往導致需要移植。隨著越來越多的人需要挽救生命的器官移植，對免疫抑制劑以防止移植後器官排斥的需求不斷成長。例如，截至2023年1月，美國器官移植網路（UNOS）的資料顯示，美國等待器官移植的人數與捐贈者器官的供應量之間存在顯著差異。 2022年，美國將進行約39,850例器官移植，其中包括已故捐贈者，與前一年同期比較增加4.6%。包括活體器官移植在內，移植器官總數達4,1,887件。這突顯了註冊捐贈者的重要作用，近 42,000 人獲得了生命的第二次開始。然而，器官捐贈的持續需求持續嚴重供不應求，比例每 10 分鐘就有一人被添加到器官捐贈等候名單中。

隨著醫療保健系統努力滿足這些患者的需求，可能會促進市場擴張。此外，藥物開發的改進正在提高這些治療方法的有效性，並支持市場擴張，以滿足器官移植免疫抑制劑日益成長的需求。

本研究的主要特點

  • 本報告對全球器官移植免疫抑制劑市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030年）的市場規模和複合年度（年複合成長率）。
  • 它還闡明了不同細分市場的潛在收入成長機會，並解釋了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 本文根據公司亮點、產品系列、關鍵績效、財務實績和策略等參數，介紹了全球器官移植免疫抑制劑市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出資訊的決策。
  • 用於器官移植的免疫抑制劑的全球市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球器官移植免疫抑制劑市場的各種策略矩陣來促進他們的決策。

目錄

第1章 調查目的和假設

  • 這項研究的目的
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 最近的趨勢
  • 合併、收購和合作
  • 法規場景
  • 主要進展
  • PEST分析
  • 波特的分析

第4章 全球器官移植免疫抑制劑市場－新型冠狀病毒感染疾病（COVID-19）影響分析

  • 經濟影響
  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 對需求和供給的影響

第5章 全球器官移植免疫抑制劑市場：依藥物類別，2018-2030

  • 鈣調磷酸酶抑制劑
  • 抗增殖劑
  • mTOR抑制劑
  • 類固醇
  • 抗體

第6章 全球器官移植免疫抑制劑市場：依移植類型分類，2018-2030

  • 腎
  • 肝
  • 心
  • 肺
  • 胰臟
  • 其他

第7章 全球器官移植免疫抑制劑市場：依配銷通路，2018-2030

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第8章 全球器官移植免疫抑制劑市場：依地區分類，2018-2030

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭形勢

  • 公司簡介
    • Astellas Pharma
    • Genzyme Corporation
    • Accord Healthcare Ltd.
    • Watson Pharmaceuticals, Inc.
    • Novartis AG
    • Mylan Laboratories, Inc.
    • GlaxoSmithKline plc.
    • Belcher Pharmaceuticals LLC
    • Leo Pharma As
    • Glenmark Pharmaceuticals Ltd.
    • TFF Pharmaceuticals, Inc.
    • TolerogenixX GmbH
    • Veloxis Pharmaceuticals Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Panacea Biotec Ltd.
    • Strides Pharma Global Pte Ltd.
    • F.Hoffman La Roche
  • 分析師觀點

第10章 章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI2495

Global organ transplant immunosuppressant drugs market is estimated to be valued at US$ 5.17 billion in 2023 and is expected to exhibit a CAGR of 3.1% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 5.17 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 3.10% 2030 Value Projection: US$ 6.4 Bn
Global Organ Transplant Immunosuppressant Drugs Market Share (%), By Drug Class, 2023
Organ Transplant Immunosuppressant Drugs Market - IMG1

One of the most complex and difficult fields in modern medicine is transplant-related medication. The majority of medications are administered to treat transplant rejection and related issues. An immunological reaction by the body to the transplanted organ occurs in transplant rejection, which frequently results in transplant failure and necessitates the removal of the organ from the recipient right away. Immunosuppressive medications and serotyping for determining donor-recipient compatibility can both help to reduce transplant rejection. The global organ transplant immunosuppressant drugs market is poised for substantial growth due to rising organ transplantation procedures worldwide. Immunosuppressant drugs are vital in preventing graft rejection post-transplantation, and the market is driven by the increasing number of organ transplantations, especially kidney, liver, heart, and lung transplants. Advancements in drug development, including targeted and personalized therapies, are enhancing drug efficacy while minimizing adverse effects. Biosimilars and combination therapies are creating competitive landscapes, potentially reducing costs of treatment. Additionally, telemedicine and remote monitoring technologies are improving patient compliance.

Market Dynamics

The market for organ transplant immunosuppressant drugs is benefiting from the rise in the prevalence of chronic diseases. Organ failure from chronic diseases like diabetes, heart disease, and renal disorders frequently results in the need for transplantation. There is a rising need for immunosuppressant medications to prevent organ rejection after transplantation as more individuals need life-saving organ transplants. For instance, as of January 2023, data from the United Network for Organ Sharing (UNOS) revealed that there existed a notable disparity between the number of individuals awaiting organ transplantation and the availability of donor organs in the U.S. Specifically, the national transplant waiting list consisted of over 107,000 individuals seeking organ transplants. In 2022, the U.S. conducted approximately 39,850 organ transplant procedures involving deceased donors, marking a notable 4.6% increase compared to the previous year. The total count of organs transplanted, inclusive of those from living donors, reached 41,887. This underscores the critical role of registered donors, as nearly 42,000 individuals were afforded a second lease on life. However, the persistent demand for organ donations remains substantially higher than the available supply, with an individual being added to the organ waitlist approximately every 10 minutes.

As healthcare systems work to accommodate these patients' requirements, the tendency promotes market expansion. Additionally, improvements in drug development are improving the efficacy of these therapies, helping the market's expansion to meet the increased need for immunosuppressant drugs for organ transplants.

Key features of the study:

  • This report provides an in-depth analysis of the global organ transplant immunosuppressant drugs market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • The study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global organ transplant immunosuppressant drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of the study include Astellas Pharma, Genzyme Corporation, Accord Healthcare Ltd., Watson Pharmaceuticals, Inc., Novartis AG, Mylan Laboratories, Inc., GlaxoSmithKline plc., Belcher Pharmaceuticals LLC, Leo Pharma As, Glenmark Pharmaceuticals Ltd., TFF Pharmaceuticals, Inc., TolerogenixX GmbH, Veloxis Pharmaceuticals Inc., Dr. Reddy's Laboratories Ltd., Panacea Biotec Ltd., Strides Pharma Global Pte Ltd., and Hoffman La Roche
  • Insights from the report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global organ transplant immunosuppressant drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global organ transplant immunosuppressant drugs market

Detailed Segmentation:

  • Global Organ Transplant Immunosuppressant Drugs Market, By Drug Class:
    • Calcineurin Inhibitors
    • Antiproliferative Agents
    • mTOR Inhibitor
    • Steroids
    • Antibodies
  • Global Organ Transplant Immunosuppressant Drugs Market, By Transplant Type:
    • Kidney
    • Liver
    • Heart
    • Lung
    • Pancreas
    • Others
  • Global Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Organ Transplant Immunosuppressant Drugs Market, By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Astellas Pharma
    • Genzyme Corporation
    • Accord Healthcare Ltd.
    • Watson Pharmaceuticals, Inc.
    • Novartis AG
    • Mylan Laboratories, Inc.
    • GlaxoSmithKline plc.
    • Belcher Pharmaceuticals LLC
    • Leo Pharma As
    • Glenmark Pharmaceuticals Ltd.
    • TFF Pharmaceuticals, Inc.
    • TolerogenixX GmbH
    • Veloxis Pharmaceuticals Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Panacea Biotec Ltd.
    • Strides Pharma Global Pte Ltd.
    • F. Hoffman La Roche

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Class
    • Market Snippet, By Transplant Type
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Recent Trends
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis
  • PORTER's Analysis

4. Global Organ Transplant Immunosuppressant Drugs Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Organ Transplant Immunosuppressant Drugs Market, By Drug Class, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Calcineurin Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Antiproliferative Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • mTOR Inhibitor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Steroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

6. Global Organ Transplant Immunosuppressant Drugs Market, By Transplant Type, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Kidney
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Liver
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Heart
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Lung
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Pancreas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

7. Global Organ Transplant Immunosuppressant Drugs Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Organ Transplant Immunosuppressant Drugs Market, By Region, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • North America
    • Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Transplant Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profiles
    • Astellas Pharma
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Genzyme Corporation
    • Accord Healthcare Ltd.
    • Watson Pharmaceuticals, Inc.
    • Novartis AG
    • Mylan Laboratories, Inc.
    • GlaxoSmithKline plc.
    • Belcher Pharmaceuticals LLC
    • Leo Pharma As
    • Glenmark Pharmaceuticals Ltd.
    • TFF Pharmaceuticals, Inc.
    • TolerogenixX GmbH
    • Veloxis Pharmaceuticals Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Panacea Biotec Ltd.
    • Strides Pharma Global Pte Ltd.
    • F.Hoffman La Roche
  • Analysts' Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact